Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Preliminary Data from Ongoing Global Phase 1/2 Study of Investigational PIM1 Inhibitor Nuvisertib in Combination with Momelotinib Showed Promising Clinical Activity in Patients with Myelofibrosis and Anemia

MPN - 674

Preliminary Data from Ongoing Global Phase 1/2 Study of Investigational PIM1 Inhibitor Nuvisertib in Combination with Momelotinib Showed Promising Clinical Activity in Patients with Myelofibrosis and Anemia

Andrew Srisuwananukorn

Poster Presenter: Andrew Srisuwananukorn

Thumbnail for Preliminary Outcomes of Treatment in Young Patients With B-Cell Chronic Lymphocytic Leukemia and Poor Prognostic Indicators Utilizing the FCR Regimen Combined With Ibrutinib and Venetoclax in a Fixed-Duration Protocol

CLL - 1376

Preliminary Outcomes of Treatment in Young Patients With B-Cell Chronic Lymphocytic Leukemia and Poor Prognostic Indicators Utilizing the FCR Regimen Combined With Ibrutinib and Venetoclax in a Fixed-Duration Protocol

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Previous 1...90 91 92 93 94 95 96...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Preliminary Safety and Efficacy of Myeloablative Orca-Q in Patients With Haploidentical Donors

CT - 931

Preliminary Safety and Efficacy of Myeloablative Orca-Q in Patients With Haploidentical Donors

Samer Srour

Poster Presenter: Samer Srour

Thumbnail for Premature Mortality in Early-Onset Multiple Myeloma in the United States, 1999-2024: Trends, Disparities, and Disproportionate Years of Potential Life Lost

MM - 742

Premature Mortality in Early-Onset Multiple Myeloma in the United States, 1999-2024: Trends, Disparities, and Disproportionate Years of Potential Life Lost

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

Thumbnail for Presentation and Clinical Outcomes in Anaplastic Large Cell Lymphoma Patients Diagnosed in Saskatchewan, Canada: A Population-based Cohort Study

TCL - 284

Presentation and Clinical Outcomes in Anaplastic Large Cell Lymphoma Patients Diagnosed in Saskatchewan, Canada: A Population-based Cohort Study

Montana Mellor

Poster Presenter: Montana Mellor

Thumbnail for Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?

AML - 1079

Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?

Aakriti Adhikari

Poster Presenter: Aakriti Adhikari

Thumbnail for Pretransplant Vitamin D Deficiency, Immune Reconstitution, and Early Outcomes After Autologous Stem-Cell Transplantation in Multiple Myeloma

MM - 1697

Pretransplant Vitamin D Deficiency, Immune Reconstitution, and Early Outcomes After Autologous Stem-Cell Transplantation in Multiple Myeloma

Prithvi Uppalapati

Poster Presenter: Prithvi Uppalapati

Thumbnail for Prevalence of CRE Colonization in Hematopoietic Cell Transplant Recipients and Its Impact on Clinical Outcomes: Experience From a Developing Country

CT - 691

Prevalence of CRE Colonization in Hematopoietic Cell Transplant Recipients and Its Impact on Clinical Outcomes: Experience From a Developing Country

Zahid Khan Zada

Poster Presenter: Zahid Khan Zada

Thumbnail for Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

AML - 849

Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors